The Hurts Precedent: Why the NFL Got the Blood Clot Decision Right, and What It Means for Player Safety Going Forward

When Jalen Hurts suffered blood clots in his shoulder during the 2023 season, the Philadelphia Eagles faced one of the most delicate decisions a franchise can confront. The quarterback who had just led them to the Super Bowl in February was suddenly dealing with a serious medical condition that required not just clarity about his recovery, but absolute certainty about his ability to return to play. The situation demanded perfect judgment, because the alternative, the consequences of getting it wrong, extended far beyond wins and losses. It involved a young man's health and career in ways that cannot be measured in fantasy points.

The NFLPA's recent response that the Eagles and the NFL handled this process appropriately is significant not because it clears away controversy, but because it represents a validation of how modern medicine, player advocacy, and team responsibility can work together when the stakes are highest. To understand why this matters, you have to understand what was actually at stake, what the protocols were designed to prevent, and why the scrutiny was so intense in the first place.

Blood clots in an athlete are not routine medical concerns that can be brushed aside with a few tests and optimistic projections. This is serious pathology. When a clot forms in a shoulder and an athlete is playing a contact sport where they will absorb impacts, jostle with three hundred pound linemen, and occasionally fall directly onto that shoulder, you are dealing with potential tragedy. A clot could dislodge. It could travel. The scenarios are the ones that keep team physicians up at night. This is why the medical clearance process for Hurts was not a rubber stamp. It was rigorous, and it needed to be.

The Eagles organization did not just say, "We think Jalen is fine, so he is playing." That would have been irresponsible. Instead, they worked within an established framework with independent medical evaluators, cardiologists, orthopedic specialists, and a team physician who understood both the medical reality and the player safety implications. The NFLPA, whose job is to protect player interests, was involved in verifying that the process was conducted fairly and with proper medical authority. This is the system working exactly as it should work, even if the system itself is sometimes imperfect.

What makes the NFLPA's clearance of the Eagles' handling so meaningful is that it comes from an organization that has every reason to be skeptical of management. The Players Association is not naturally inclined to give anyone a pass. They represent the players. Their instinct is to protect their members, often against the league itself. If the NFLPA found problems with how the Eagles handled Hurts' clearance, we would have heard about it loudly. They would not have certified the process. The fact that they did speaks to something important about how this particular situation was managed.

Consider the historical context here. For decades, the NFL and its teams got medical decisions wrong. Players played injured when they should not have. Concussions were mishandled. Return-to-play protocols were inadequate. Team physicians were sometimes caught between their responsibility to the player and their employment by the team. The league has spent years trying to modernize its approach to player safety, not because they suddenly discovered their conscience, but because the evidence became overwhelming, because retired players suffered long-term consequences, and because lawsuits and settlements eventually forced accountability.

The Hurts situation could have been mishandled in a dozen different ways. The Eagles could have rushed him back without proper specialist consultation. They could have hidden the severity of his condition. They could have pressured the medical staff to clear him prematurely because they were desperate to get their star quarterback back for a crucial game. Any of those scenarios would have been familiar iterations of how the business of football had previously operated. The fact that none of that appears to have happened is not a small thing.

Jalen Hurts himself deserves credit here as well. The quarterback could have pushed to return faster. He could have minimized his injury to teammates and coaches. Instead, he appears to have taken the process seriously, worked with the medical staff, and accepted the timeline that was medically appropriate. That is the kind of maturity that does not always happen in a league where playing time and competitiveness create constant pressure to return to the field.

The NFL's involvement in clearing the process is equally important to examine. The league has an obvious interest in keeping star players on the field. Hurts is one of the most exciting players in football. The Eagles were contenders. Financially and competitively, the league would have benefited from his return. Yet the league's medical staff, working with independent physicians, still conducted a thorough evaluation. They did not cut corners. They did not skip steps. The process took time because the condition required time to properly assess.

This is the kind of precedent that matters for player safety moving forward. When a future player suffers a serious medical condition, they will look back at how Hurts was handled. They will see that the Eagles did not punish him for being injured. They did not pressure him to play hurt. They did not cut corners in the evaluation process. That sets a standard. It creates an expectation. It means that the next player in a similar situation can reasonably expect that their team will treat them with medical seriousness rather than with competitive desperation.

The absence of punishment is also worth examining carefully. The NFLPA's response that the Eagles will not face penalties is perhaps more important than it might initially appear. If the league had fined the Eagles or docked draft picks for handling a medical clearance appropriately, it would have sent a chilling message. It would have suggested that teams should be afraid of being transparent about medical issues, afraid of taking time with complicated evaluations, afraid of erring on the side of caution. That kind of incentive structure destroys player safety. The league's decision not to punish the Eagles actually reinforces the idea that doing things the right way, even when it is inconvenient or expensive, is the priority.

There is also something worth noting about the timing of this validation. It came after the fact, after Hurts had played the game in London against the Jacksonville Jaguars, after he had demonstrated on the field that the medical clearance appeared to have been sound. This was not a pre-game proclamation of confidence. This was a retrospective examination of the process, which is exactly what you want. It allowed time for reality to conform or contradict the medical prediction.

The broader implications for quarterback health and risk management in the NFL are substantial. Quarterbacks are special players. They are the most valuable position on the field, and they are also uniquely vulnerable because every play puts them in potential contact with defensive players. When a quarterback has a serious medical condition, the stakes for the franchise are enormous. Teams have financial investments, season projections, and organizational strategies that depend on quarterback availability. Yet despite all of that, the Eagles organization and the NFL medical staff apparently decided that proper medical evaluation was more important than speed. That is exactly the philosophy that player safety advocates want to see codified and repeated.

Looking at this situation with the kind of perspective that history provides, the Hurts blood clot case could become a blueprint for how modern NFL organizations should handle serious medical conditions. It is not perfect. No process is. But it appears to have functioned as designed. Independent medical evaluation happened. Proper specialists were consulted. The team and the league worked together rather than at cross purposes. The player was not punished for the condition. The timeframe was appropriate to the medical reality rather than to the competitive schedule.

In a league that has sometimes treated player health as an afterthought, sometimes treated it as a public relations problem, and sometimes treated it as something to be managed quietly and quickly, the Hurts situation represents what conscientious stewardship actually looks like. The NFLPA's validation of the process is not just a legal clearance. It is an acknowledgment that when it matters most, when a player's long-term health and career are on the line, the Eagles and the NFL did things the right way.